uniQure
QURE
#5384
Rank
โ‚ฌ1.16 B
Marketcap
18,70ย โ‚ฌ
Share price
2.06%
Change (1 day)
170.69%
Change (1 year)

uniQure (QURE) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚ฌ0.56 Billion

According to uniQure's latest financial reports the company's total liabilities are โ‚ฌ0.56 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

uniQure - Total liabilities on balance sheet (from 2012 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ0.54 B-4.11%
2023-12-31โ‚ฌ0.56 B164.47%
2022-12-31โ‚ฌ0.21 B13.27%
2021-12-31โ‚ฌ0.18 B140.21%
2020-12-31โ‚ฌ78.44 M-30.02%
2019-12-31โ‚ฌ0.11 B35.99%
2018-12-31โ‚ฌ82.43 M-17.77%
2017-12-31โ‚ฌ0.10 B-16.73%
2016-12-31โ‚ฌ0.12 B-2.3%
2015-12-31โ‚ฌ0.12 B133.86%
2014-12-31โ‚ฌ52.69 M57.76%
2013-12-31โ‚ฌ33.4 M455.42%
2012-12-31โ‚ฌ6.01 M-28.24%
2011-12-31โ‚ฌ8.38 M-7.33%
2010-12-31โ‚ฌ9.04 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
โ‚ฌ69.17 B 12,107.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚ฌ70.78 M-87.51%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
โ‚ฌ0.30 B-46.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
โ‚ฌ0.21 B-62.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ56.72 B 9,909.63%๐Ÿ‡ซ๐Ÿ‡ท France
BioMarin Pharmaceutical
BMRN
โ‚ฌ1.33 B 136.22%๐Ÿ‡บ๐Ÿ‡ธ USA